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Purpose: The purpose of this study was to determine the effects of increased shear stress 
on the aggregability ofplatelets as they traverse a long, small-caliber (6 mm) Dacron graft 
in the dog and on the surface thrombosis and endothelialization f such a graft. 
Methods: Each of nine dogs received bilateral carotid-femoral artery grafts, approximately 
75 cm long, for 3 months; one graft of each pair had a distal femoral arteriovenous fi tula 
to produce ahigher shear ate than the contralateral graft. Platelet aggregation scores were 
determined on blood withdrawn from the external jugular vein and from the proximal and 
distal ends of the grafts in each animal. Graft flow rates, which were used in the 
computation ofshear stress, and luminal pressure gradients through grafts were measured 
during surgery and specimen retrieval. Specimens were studied with light microscopy after 
hematoxylin and eosin and immunocytochemical st ining and by scanning electron and 
transmission electron microscopy to evaluate the nature, composition, and thickness of the 
flow surface lining, as well as the transmural healing. 
Results: Two high-shear stress and two low-shear stress grafts occluded unilaterally; five 
dogs had bilaterally patent grafts, allowing comparative analyses. All subjects had low 
platelet aggregability with aspirin. Platelet aggregation scores taken from proximal and 
distal ends of the grafts were not significantly different. The high-shear stress grafts had 
significantly more endothelial-like c ll coverage (p < 0.0371) than the low-shear stress 
grafts, less flow-surface thrombus (p < 0.0056), and a thinner surface lining (p < 
0.0029), on both the neointima nd pseudointima. 
Conclusions: In subjects with low platelet aggregation scores, long Dacron grafts do not 
elevate platelet aggregability ofblood flowing through them. High-shear stress grafts have 
less flow surface thrombus, more endothelialization, a d a thinner surface lining than do 
low-shear stress grafts. (J VASC SURG 1995;22:382-92.) 
Studies have shown that increased flow shear 
stress can improve graft patency and decrease intimal 
hyperplasia. 18However, its effects on the aggrega- 
bility of platelets as they traverse a long, small-caliber 
(6 mm) graft, and on the endothelialization f  such 
a prosthesis, have not been studied. Previously we 
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reported a long (about 75 cm) carotid-femoral bypass 
experimental model in the dog, which is relevant to 
the clinical procedure of axillofemoral bypass.9 In this 
study we extended the model to include a carotid- 
femoral artery bypass on each side, one of which had 
a distal arteriovenous fistula, to allow comparative 
study of the effect of increased shear stress on platelet 
aggregability and healing in these long grafts in the 
subcutaneous position of the same animal (Fig. 1). 
METHODS AND MATERIAL  
Nine dogs (two male, six female, and one 
neutered female) with an average weight of 24.3 + 
3.1 kg (range 23 to 29 kg) were used in this study. 
All animals were cared for in compliance with the 
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Fig. 1. Drawing of surgical model for bilateral carotid- 
femoral bypasses with arteriovenous (A-V) fistula on one 
side. 
"Principles of Laboratory Animal Care" and the 
Guide for the Care and Use of Laboratory Animals 
(National Institutes of Health publication No. 80- 
23, revised 1985). 
Platelet aggregation measurement 
The method for determining platelet aggregabil- 
ity and expressing its value as a numeric platelet 
aggregation (PA) score has been described previ- 
ously) °011 PA scores, both baseline and after medi- 
cation with aspirin, were determined before surgery. 
Only animals with a medicated PA score of less than 
30 were included./1 One hour before specimen 
retrieval, three blood samples were taken, one from 
the external jugular vein for reevaluation of PA score 
stability and two simultaneously from the proximal 
and distal ends of the patent grafts to evaluate platelet 
activation through the long bypass. The subjects were 
conscious but in a nonagitated state, to exclude the 
influence of preanesthetic and anesthetic agents./2,13 
Surgical techniques 
Subiects received 0.25 mg/kg acepromazine and 
0.01 mg/kg atropine, after which general anesthetic 
was administered with 5 to 10 ml 4% thiamylal 
intravenously and maintained with 0.5% to 1.0% 
halothane and a 2:1 mixture of nitrous oxide and 
oxygen through a closed-circuit respirator. The 
subject yeas then placed in the lateral position with the 
top rear leg slightly stretched and everted. The side 
operated on first was alternated from case to case. 
After 6 to 8 cm of the proximal carotid and femoral 
arteries was mobilized, a subcutaneous channel was 
Fig. 2. Comparison of two gross specimens that had been 
implanted in same dog. A, HSS bypass. B, LSS bypass. 
(A-V, Arteriovenous; Rt, right; Lt, left.) 
made between the two exposed arteries with a flexible 
plastic tunneler. An 80 cm long, 6 mm diameter, 
externally supported Dacron Bionit graft (Bard 
Vascular Systems Division, C.R. Bard, Inc., Billerica, 
Mass.), preclotted with autogenous blood by a 
four-step method, ~4 was introduced into the subcu- 
taneous channel and secured with end-to-side anas- 
tomoses. The average implanted graft length was 
72 _+ 3 cm. The common femoral artery was ligated 
proximal to the first branch below the inguinal 
ligament (craniofemoral branch). The side receiving 
the distal-femoral rtcriovenous fi tula (15 mm long) 
was alternated between cases: the fistula anastomosis 
was performed with 7-0 Prolene, 2 cm distal to the 
graft-femoral artery anastomosis. One milligram per 
kilogram heparin was given intravenously a few 
minutes before allowing blood into the graft. Ten 
minutes after flow had been established, an equal 
dose of protamine was given. After wound closure 
the subject was repositioned, and a contralateral 
carotid-femoral bypass, either with or without a 
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Table I. Results of rheologic and flow surface studies for HSS and LSS grafts 
Study group data (n = 5) HSS LSS p Value 
Flow rate (ml/min) 
Beginning of study 
End of study 
Calculated shear stress (dynes/cm 2) 
Beginning of study 
End of study 
Ratio of calculated shear stress 
(dynes/cm 2) 
Beginning of study 
End of study 
Luminal pressure gradient 
(n~n Hg) 
Beginning of study 
End of study 
560 -+ 85 112 -+ 34 0.0003 
623 -+ 67 91 +- 23 0.0001 
15.4 -+ 2.3 3.1 -+ 0.9 0.0003 
17.1 -+ 1.8 2.5 -+ 0.6 0.0001 
5.0 : 1.0 
6.8 : 1.0 
99+ 17 to 96+ 17 109+ 15 to 109-+ 13 
100 + 13 to 96 + 14 112 -- 13 to 111 _+ 13 
NS for both columns 
NS, Not significant. 
Table II. Comparative results of thrombus urface coverage and endothelial-like cell coverage from 
5 cases with bilaterally patent grafts 
Thrombus-covered surface (%) Endothelial-like cell coverage score (%) 
Case HSS LSS HSS LSS 
V-112 2.5 31.6 65.7 56.7 
V-115 2.1 47.6 22.1 1.5 
V-138 0.9 88.3 64.6 7.0 
V-153 7.7 86.0 23.4 3.5 
V-167 4.0 93.6 32.7 12.0 
Mean +_ SD 3.4 -+ 2.6 69.4 _+ 27.9 41.7 -+ 21.8 16.1 -+ 23.0 
(p < 0.0056) (p < 0.0371) 
distal arteriovenous fistula, was performed. Appro- 
priate antibiotics were given on the day of surgery 
and for the next 10 days thereafter. All subjects 
received two tablets (162 mg) of pediatric aspirin 
from the day before surgery until the end of the study. 
Graft patency was followed by daily Doppler exami- 
nations for the first 3 weeks and then twice weekly 
throughout the remainder of the 3-month implant 
period. 
Rheologic measurement and evaluation 
During surgery, on completion of the anasto- 
moses and stabilization of the flow after declamping, 
the flow rate of the blood through the bypass was 
measured with a two-channel Transonic flowmeter 
(model T-208; Transonic System Inc., Ithaca, N.Y.). 
Because of the distal femoral arteriovenous fistula, 
and to prevent urbulence from affecting the mea- 
surement, wo 4 mm flow probes were placed around 
the carotid artery, one proximal and one distal to the 
graft-carotid artery anastomosis. The bypass flow 
rate was obtained by subtracting the reading of the 
distal probe from the proximal reading. This method 
of measurement was used again just before retrieval 
of the specimen. 
Average wall shear stress in the grafts (in dynes 
per square centimeter) was calculated according to 
the Hagen-Poiseuille formula4,:5: 
4~Q 
"i'= Tl'~ 3
where ~ is the viscosity of blood (assumed to be 
0.035 poise), Q is the mean flow rate (in milliliters 
per second), and r is the graft radius (in centimeters), 
in this case 0.3 cm for the 6 mm graft. The ratio of 
shear stress at the flow surface of the wall between the 
two grafts can be calculated simply by the ratio of 
their mean flow rates, because the elements in the 
formula with the same value can be omitted. 
The pressure gradient hrough the bypass was 
measured at operation shortly after implantation and 
again at death. Two 23G x a/4 butterfly needles were 
inserted into the graft lumen at the proximal and 
distal ends of the graft and connected through the 
pressure fines with the pressure transducers (model 
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P23XL; Viggo-Spectramed, Oxnard, Calif.) and a 
multichannel pressure monitor (model IM Bedside 
Monitor; Honeywell Inc., Pleasantville, N.Y.). Mean 
pressures at the proximal and distal ends of the bypass 
were re, corded. 
SPECI2VIEN RETRIEVAL AND ANALYSIS 
After blood draws, the animals were immedi- 
ately anesthetized in the same manner as that used 
for graft placement and given 3 mg heparin/kg body 
weight intravenously. Each graft was then ex- 
posed by a continuous incision overlying its 
outline. 
After gross observations and theologic measure- 
ments, the subjects were exsanguinated and each 
graft, with its external capsule and a generous 
segment of the adjacent carotid and femoral rteries, 
including the arteriovenous fistula~ if present, was 
excised. The graft was opened longitudinally, 
flushed gently with phosphate-buffered saline so- 
lution, pinned flat, and photographed. The appear- 
ance of the flow surface was evaluated grossly and 
under stereoscopic magnification and mapped on 
grid paper for calculation of the percentage of 
thrombus urface coverage (thrombus urface cov- 
erage score). The entire graft was divided into five 
zones of equal length from the proximal to distal 
ends. Four adjacent tissue blocks (each i x 0.4 cm), 
which were considered the most characteristic of 
each zone, were taken, as were similar blocks across 
each anastomosis. In addition, tissue blocks were 
taken from other areas of interest. One block was 
embedded in resin mad later sectioned and stained 
with hematoxylin and eosin for light microscopic 
study. One block was embedded in paraffin, sec- 
tioned, and stained, for both factor VIII/yon Wille- 
brand factor (FVIII/vWF) (code No. M-616; Dako 
Corp., Carpinteria, Calif.), to allow identification of 
endothelial cells, and for smooth muscle cell ~-actin 
(code No. M-851; Dako Corp.), to allow identi- 
fication of smooth muscle cells. The remaining two 
tissue blocks were routinely taken from each zone 
for scanning electron microscopic and transmission 
electron microscopic study, but examinations were 
performed later only on those blocks adjacent o 
areas where endothelial cells had been identified 
with hematoxylin and eosin and FVIII/vWF stain- 
ing. The same studies were also done on the four 
tissue blocks taken from areas crossing both the 
proximal and distal anastomoses and other areas of 
special interest. The flow surface of the rest of the 
graft was then stained with 0.3% silver nitrate to 
check for the presence and extent of endothelial-like 
Fig. 3. Studies used to verify endothelial nature of c lls. 
A, AgNO 3 staining shows endothelial-like cellborders. 
(Original magnification x45.) B, Positive FVIII/vWF 
stain on flow surface. (Original magnification × 85.) C, 
Scanning electron microscopy. (Original magnification 
× 764.) D, Transmission electron microscopy. (Original 
magnification × 4070.) 
cell outlines and to allow percentage quantification 
of endothelial-like cell coverage on the surface. The 
details of the techniques used have been described 
previously. 16,17 Quantitative data were expressed by 
mean + SD. For statistical comparisons, which 
were performed for the dogs with bilaterally patent 
grafts at the end of the study, we used the paired 
Student test. The standard for statistical signifi- 
cance was p < 0.05. 
JOURNAL OF VASCULAR SURGERY 
386 Wu et al. October 1995 
Table HI. Comparison of average neointimal thickness at the anastomotic areas between HSS and 
LSS grafts 
HSS graft (n = 5) (lain) LSS graft (n = 5) (tzm) 
Proximal Distal Proximal Distal 
Host Arterial Side Graft Side Host Arterial Side Graft Side Host Arterial Side Graft Side Host Arterial Side Graft Side 
158 ± 120 112 ± 36 138 ± 97 194 ± 142 250 ± 220 322 ± 236 290 ± 255 436 ± 225 
There are statistically significant comparisons between the proximal graft sides (p < 0.021) and the distal graft sides (p < 0.015) of  HSS 
and LSS grafts. 
RESULTS 
Graft patency. In the nine dogs, there were two 
unilateral occlusions of high-shear stress (HSS) 
grafts, one on the second and one on the fourteenth 
postoperative days, and two unilateral occlusions of 
low-shear stress (LSS) grafts, one on the second and 
one on the fifth postoperative days. In five animals 
both grafts were patent at the completion of the 
3-month implantation. Comparative data analyses 
were performed on these grafts. 
Platelet aggregation evaluation. The PA score 
base values in the five dogs with bilateral patent grafts 
ranged from 4.6 to 25.5, with an average of 
14.2 + 9.4. After aspirin, the average medicated, 
preoperative alue was 11.1 + 4.8. At the end of the 
study, before specimen retrieval, the average PA score 
determined from blood samples taken from the 
external jugular vein was 7.4 _+ 4.6 (range 5.2 to 
15.3). 
Average PA scores determined for the blood 
samples withdrawn from the upper and lower ends of 
each of the five graft pairs were 8.3 -+ 6.3 proximally 
and 8.5 + 4.2 distally (p > 0.92) for the HSS grafts 
(n = 5) and 8.0 + 4.9 proximally and 8.6 + 4.9 
distally (p > 0.68) for the LSS grafts (n = 5). 
Rheologic observations. Numeric data are given 
in Table I. The distal femoral arteriovenous fistula 
provided an average fivefold to sixfold increase in 
calculated shear stress at the graft wall, compared 
with the grafts without fistulas (p < 0.0001), and 
measurements at the beginning of the study period 
were comparable within 10% to 20% to those just 
before retrieval. In both the HSS and LSS grafts, 
average luminal pressures howed no significant 
change from proximal to distal in the bypass. 
Healing evaluation. 
Gross observations and flow surface studies. The five 
bilaterally patent cases had no hematoma formations 
or seroma collections around the grafts. In four pairs, 
both the LSS and HSS grafts had tight and firm 
perigraft issue attachment with a thin, translucent 
fibrous capsule along the entire graft length, except 
for one LSS and one HSS graft (in two different 
animals) that had loose perigraft nssue attachment a
the proximal 10 to 15 cm where the neck frequently 
turns. In one animal the external capsule was un- 
evenly attached bilaterally in both the neck and groin. 
The anastomotic areas of both the HSS and LSS 
grafts were similar. Both were covered by pannus 
ingrowth from the host artery. This tissue was free of 
thrombus and extended 3 to 7 mm onto the graft 
flow surface. The sutures used for the anastomoses 
could be seen easily through this thin, translucent 
pannus extension, which appeared to be slightly 
thicker in the LSS grafts. 
Beyond the perianastomotic zones, the majority 
of the flow surfaces of HSS and LSS grafts had very 
different appearances. In the five HSS grafts, a thin, 
glistening, white, translucent lining covered an aver- 
age of 96.6% of the flow surface, whereas cattered 
small patches of thin, red thrombus covered the 
remaining 3.4% of the flow surface (Fig. 2; Table II). 
For the five LSS grafts, thrombus covered 69.4% of 
the surface (Fig. 2; Table II). Silver nitrate staining 
revealed endothelial-like c ll coverage (Fig. 3, A) of 
41.7% _+ 21.8% of the flow surfaces of the HSS 
grafts and 16.1% + 21.8% of the LSS grafts (p < 
0.0371) (Table II). The endothelial-like c lls on both 
the HSS and LSS graft flow surfaces appeared only 
on the thrombus-free areas. Because of this, a 
comparison was made of the extent of endothelial- 
ization of the areas not covered by thrombus in both 
graft categories. Forty-four percent and 53% of these 
clear areas were covered by endothelium for the HSS 
and LSS groups, respectively (no significant dif- 
ference). 
Microscopic study. The perianastomotic areas of all 
grafts were completely healed, with full wall tissue 
presence and a thin layer of smooth neointima 
consisting of smooth muscle cells covered by endo- 
thelial cells. Average neointimal thicknesses on both 
sidcs of the anastomoses arc shown in Table III. Both 
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Fig. 4. Comparative thicknesses ofneointima and pseudointima. HSS (A and C) and LSS (B 
and D) grafts how increased thickening of neointima and pseudointima of latter. A and B were 
implanted in same animal, swere C and D. (Clear areas on lower righthand sides of A and C 
are spaces previously occupied by supported rings of grafts.) (Hematoxylin and eosin stain. 
Original magnification x 95.) 
the proximal and distal neointimal thicknesses on the 
graft side of the LSS anastomoses were significantly 
thicker than the proximal (p < 0.021) and distal 
(p < 0.015) ends of the HSS grafts. 
The following microscopic observations, which 
do not include the anastomotic area, were based on 
tissue samples taken from 25 zones for each of the 
HSS and LSS groups (five zones for each graft of five 
bilaterally patent pairs). The major differences be- 
tween the HSS and LSS grafts were the nature, 
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Fig. 5. Verification of smooth muscle cells in neointima nd external capsule by smooth muscle 
a-actin staining and demonstration of fewer smooth muscle cells in neointima ofHSS (A) than 
in LSS (B) grafts implanted in same animal. (Original magnification × 100.) 
composition, and thickness of the internal capsule on 
the flow surface. On 14 of 25 zones on the HSS 
grafts, and seven of 25 zones on the LSS grafts 
(p < 0.044), the internal capsule had a layer of 
neointima (Fig. 4,A andB) that consisted of multiple 
layers of smooth muscle cells covered with endothe- 
lial cells. Endothelial cells were identified by 
FVIII/vWF staining and scanning electron micro- 
scopic and transmission electron microscopic studies 
(Fig. 3, B through D). The average thickness of 
neointima was 210 + 71 Ixm (n = 14) for the HSS 
grafts, compared with 447 _+ 200 ~tm (n = 7) for 
the LSS grafts (p < 0.028). Smooth muscle cells in 
the neointima were identified by smooth muscle 
(x-actin staining, which demonstrated that the 
thicker neointima on LSS grafts contained many 
more smooth muscle cells than on the HSS grafts 
(Fig. 5). 
On the remaining 11 of 25 zones of the HSS 
grafts and 18 of 25 zones of the LSS grafts, the 
internal capsule consisted of a layer of homogenous 
fibrin material for the HSS grafts and a thicker 
thrombus layer for the LSS grafts (Fig. 4, C andD). 
The average thickness of pseudointima was 141 + 
102 Ixm for the HSS grafts, compared with 325 + 
246 txm for the LSS grafts (p < 0.019). For both 
HSS and LSS grafts, the pseudointima was partially 
organized in the basal portions in some and unorga- 
nized in others. 
Overall, the thickness of the internal capsules of 
all 25 zones of the HSS grafts averaged 180 + 91 
txm, and the LSS grafts averaged 363 _+ 242 p~m 
(p < 0.003). 
The degree and extent of tissue ingrowth into the 
interstices of the graft wall did not differ between 
HSS and LSS grafts. For the areas with tight and firm 
perigraft issue attachment, most of the graft inter- 
stices had full-wall, or near full-wall, tissue presence. 
Smooth muscle oL-actin staining showed that smooth 
muscle cells in the graft interstices were rare and, 
when present, associated with microvessels. The 
neointima was formed of smooth muscle cells sur- 
faced by endothelial cells. In some regions of both the 
HSS and LSS grafts, we observed this same type of 
neointima in areas in which there was no continuity 
of tissue through the interstices to the perigraft 
sources; the interstices were filled, instead, with 
fibrin. 
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DISCUSSION 
Theoretically, increased flow shear stress, given an 
optimal graft diameter, should improve graft patency 
rates.~-3 However, in this study there was no differ- 
ence between the patency rates of HSS and LSS 
grafts, perhaps because all study subjects had low 
platelet aggegability. In a recent clinical study, we 
demonstrated that evaluation of platelet aggregability 
aids determination of primary patency for femo- 
ropopliteal grafts, compared with other risk factors 
such as flow runoff, history of smoking, age, etc. n 
In five animals both grafts were patent at 3 
months, despite significantly increased flow surface 
thrombus on the LSS grafts (Table II). It is possible 
that most of these LSS grafts would have undergone 
delayed closure during longer periods of implan- 
tation) 8
The difference in thrombus coverage may be 
related to the reduced time required for a platelet to 
traverse the HSS grafts (2.3 vs 13.5 seconds for the 
LSS grafts). In 1979 we suggested that there is a 
thrombotic threshold velocity for any given sur- 
face. 19'2° The blood/material interaction i volved in 
the dynamic Vroman effect 21,22 of adsorption and 
desorption of proteins requires time, which decreases 
proportionately to the increase of shear stress. The 
lack ofthrombus on the HSS graft surfaces may have 
been due to both the continuous weeping action 
generated by the high shear stress and the shorter 
time in which the thrombotic reaction could occur. 
These effects may also explain the greater thickness of 
the neointima nd pseudointima of the LSS grafts. In 
this regard it is pertinent that Klose et al.23 suggested 
that high shear stress decreases the extent of PA on 
the flow surface. 
Kohler et al.6 and others 7,8'ls,24,2s have demon- 
strated a correlation between low shear stress and a 
thick surface intima and suggested that this may be 
related to an autoregulatory role of the endothelium, 
associated with expression of growth factors, in 
determindng luminal diameter. Our results howing 
significantly thicker neointima in the LSS group 
support heir findings and suggestions. 
Clagett et al., 26 Ito et al., 27'2s and Brophy et al.29 
have reported persistent platelet activation during the 
implantation of a Dacron graft. Our study results 
showed that the study subjects' PA scores remained 
at a stable low level without increase through the 
3-month study period, indicating that platelets were 
not activated further by passage through the two long 
grafts. This lack of activation can perhaps be attrib- 
uted to the positive ffect of aspirin on those subjects, 
which suggests that it is important to determine if a 
subject has a favorable response to aspirin before graft 
implantation, ,3° 
In this study the ratios of total endothelialized 
areas/thrombus-free areas for both the HSS and LSS 
grafts were similar. This suggests that the chemistry 
of the thrombus-free, proteinaceous flow surface is 
more conducive to endothelial cell formation than is 
thrombus, whether these cells arise from transinter- 
stitial through-wall microvessel ingrowth 31-33 or are 
deposited from the circulation. 3436 
In summary, for subjects with medicated low PA 
scores, platelet aggregability was not elevated in 
blood passing through the long grafts, regardless of 
whether the shear stress was high or low. With 
increased flow shear stress, mural thrombus deposi- 
tion was decreased, aswas the thickness of the surface 
lining. Although total surface ndothelialization was 
increased in the HSS environment, he ratio of 
endothelialized areas/thrombus-free ar as was not. 
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DISCUSSION 
Dr. Ted Kohler (Seattle, Wash.). You have made five 
important observations. First, you observed increased flow 
and calculated shear in grafts with a distal arteriovenous 
fistula. Shear stress was calculated with the Hagen- 
Poiseuille formula, which is valid for steady, laminar flow 
of Newtonian fluids in straight ubes. It is not accurate in 
other situations, particularly if there is turbulence. Did you 
attempt to characterize flow in the grafts, for example, by 
obtaining velocity waveforms with ultrasonography? 
You found no measurable increase in platelet aggrega- 
tion over time or in blood passing through the graft. Dr. 
Sauvage's group has demonstrated the correlation of 
increased platelet aggregation scores and graft failure in 
their dog model. However, I am not sure that this test is a 
sensitive way to determine the extent of platelet activation 
by vascular grafts. A very small percentage ofthe circulating 
platelets is exposed to the Dacron surface with each pass 
through the graft. Those that are activated are likely found 
near the wall, whereas blood samples are presumably taken 
from center stream and yield samples of the general platelet 
pool. Further, one cannot detect overall differences in 
platelet activation caused by the fistula in this experiment 
because all animals had a fistula. Did you consider 
measuring circulating products of platelet activation, plate- 
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let count, or platelet survival after placement of Dacron 
grafts in separate animal groups with and without a fistula? 
In a model designed to prohibit graft healing by 
capillary ingrowth, you recently resurrected an old hypoth- 
esis of graft endothelialization from fallout of circulating 
endothelial cells. In the current experiment you hypoth- 
esize that the same phenomenon accounts for the finding of 
endothelium inareas in which there was no tissue ingrowth 
into the Dacron. As far as I know, the search for circulating 
endothelial cells has been unsuccessful. Could these cells be 
shed from the proximal growing edge of endothelium? Is
it not equally possible that these endothelial cells grew in 
from adjacent areas in which there was tissue ingrowth or 
that early ingrowth in these areas broke down over time 
leaving only the endothelialized surface? Observations at 
earlier times would help resolve this question. 
The finding of decreased thickness of the neointima in 
high-flow grafts is consistent with the observations ofmany 
others, including our own work with polytetrafluoroeth- 
ylene grafts. We are investigating the possibility that 
increased production of nitric oxide in response to altered 
flow inhibits smooth muscle cell growth. You are faced 
with a sampling problem in studying such long grafts and 
took histologic sections from "representative areas" rather 
than from predetermined measured intervals along the 
graft. This may have led to observer bias. You may wish to 
comment. 
The finding of increased thrombus-free area and 
endothelialization i high-flow grafts is fascinating. In 
many systems platelet activation is increased in areas of 
increased flow, yet you found a marked inhibition of 
thrombosis on the surface of high-flow grafts. On smooth 
polymers, there is a low rate of platelet interaction with the 
surface, and thrombosis is limited by the kinetics of this 
interaction. On more thrombogenic surfaces, like Dacron, 
thrombosis is thought o be diffusion limited: the more 
products of thrombosis that are delivered, the more 
thrombus develops. You postulate that the very high flow 
in your model caused washout of thrombotic products. 
This is possible if the important molecules involved are 
highly diffusable and leave the boundary layer rapidly. An 
alternative xplanation is that the high-flow grafts endo- 
thelialize to a greater extent han low-flow grafts, leading to 
less thrombus-prone surface on these grafts. The answer to 
which came first, thrombosis inhibiting endothelialization 
or endothelialization i hibiting thrombosis, can be an- 
swered by studying earlier time points. 
Dr. Moses Hong-De Wu. Dr. Kohler's discussion 
raised five main questions, one regarding the calculation of 
shear stress. I agree with Dr. Kohler's comments. Flow 
shear stress presents acomplex engineering issue. As far as 
we know, there seems to be no direct way to measure shear 
stress in in vivo grafts, especially with the turbulence. 
In this study we did not measure velocity with 
ultrasonography. The advantage of measuring the velocity 
is that the flow samples can be aimed at the center of the 
flow or near the wall. If the average velocity is obtained, and 
converted to shear stress, the Hagen-Poiseuille formula still 
has to be used and the same problems will be encountered 
unless a precise velocity profile or gradient at the wall can 
be defined. However, this would be difficult to achieve. 
With regard to the measurement of platelet-release 
products for evaluating platelet aggregability in separate 
animal groups with or without arteriovenous fistula, 
because our objectives were to study in the same animal the 
effect of increased shear stress on graft healing and platelet 
aggregability, we did not evaluate blood samples from 
separate animal groups with and without arteriovenous 
fistulas. Certainly this is a valuable suggestion to look into 
in the future. In this study we did not evaluate platelet- 
release products. 
In a previous tudy we measured the circulating platelet 
products for the ratio of thromboxine B2/6-keto prosta- 
glandin Fl~ and found that there is a close correlation 
between these measurements and platelet aggregability. 
With regard to the fallout endothelialization, this study 
did not focus on fallout endothelialization, and the model 
was not designed for that purpose. Although I did not 
mention the fallout healing in this presentation, the 
manuscript briefly describes areas where the surface was 
endothelialized espite an absence of interstitial tissue 
ingrowth. Our previous experimental report has confirmed 
the fallout healing phenomenon, and a research group in 
Italy (Sbarbati et al., Blood 1991;4:764-9) has demon- 
strated endothelial cells in circulating blood after catheter- 
ization injury in the human being. In addition, the Texas 
Heart Institute 34 has reported the presence of endothelial 
cells on the surface lining of a left ventricular assist device, 
for which fallout endothelial cells seemed to be the only 
source. 
Dr. Kohler is right that early observation would be 
helpful in resolving this question. Currently we are 
studying it in a different model, also with earlier observa- 
tions. 
With regard to the method for taking tissue samples for 
histologic evaluation, in this study the total flow surface 
thrombus coverage and endothelial cell coverage were 
determined, in addition to the histologic studies of the 
nature and thickness of the flow surface as parameters for 
evaluating the effect of increased shear stress on graft 
healing. Because the graft was so long, taking tissue samples 
from the predetermined areas for histologic evaluation 
certainly is one of the routine scientific approaches. My 
opinion is that taking samples under direct vision from the 
most representative area of each zone would enable the 
study sample to reflect closely the healing reality. This may 
be considered a bias, but an acceptable bias and method of 
sampling. 
With regard to the increased thrombus-free areas and 
endothelialization i  high-shear grafts, and'which came 
first, the phenomenon of an increased thrombus-free area 
associated with increased flow rate, or shear stress, has been 
reported repeatedly and observed by us and other groups. 
Actually, many years ago we explained this phenomenon 
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with the concept of a thrombus threshold velocity. 
Endothelial cells are known to be able to activate plas- 
minogen to plasmin for thrombolysis. In our study not all 
the thrombus-free areas were covered by endothelial cells. 
Instead it happened to only about 44% to 53% of the 
thrombus-free areas. This may suggest, in our study, that 
the primary mechanism is endothelial cells growing onto 
the preexisting thrombus-free surface. Of course, throm- 
bolysis generated by endothelial cells during healing in this 
study cannot be excluded. 
Dr. Christopher K. Zarins (Stanford, Calif.). We 
have shown similar results in an experimental model of 
iliofemoral bypass with an arteriovenous fi tula. We were 
able to limit the amount ofintimal thickening. On the other 
hand, I am not aware that in clinical situations creation of 
an arteriovenous fistula below a bypass graft significantly 
increases graft patency. Are you using arteriovenous fi tulas 
to try to maintain graft patency and, if so, is it effective? Do 
you find similar limitation of intimal thickness at the 
anastomosis in such situations? 
Second, I want to ask about the model itself and the 
concept of studying the physiology of high-shear stress 
with an arteriovenous fistula model. It is quite different 
from what happens in real life because in real life the 
vascular system is exposed to increases in shear stress, but 
they are transient and intermittent, such as you get with 
exercise. Most of the time shear stress is quite low. Thus the 
artery is normally exposed to a large range in shear stresses. 
However, with an arteriovenous fi tula it is constantly high 
24 hours a day. I believe this may result in responses that 
are quite different from normal as shear stress fluctuates. 
Can you comment on that? 
Dr. Wu. Actually, this is purely an experimental study 
of great healing, and it does not imply clinical application 
of a distal arteriovenous fistula. Several years ago Dr. 
Dardik and others preferred a common arteriovenous 
ostium distal to the distal anastomosis for below-knee 
bypass and achieved some improvement in patency rates 
with this technique. 
Again, shear stress is a complex engineering issue. I 
agree that there is constant change in shear stress. If  we look 
at the model from another point of view and forget the 
term shear stress, the arteriovenous fistula definitely con- 
stantly increases the flow rate, and from the data I have 
presented we probably could say that we learned the effect 
of the increased flow rate on graft healing instead of the 
term shear stress. 
Dr. Calvin B. Ernst (Detroit, Mich.). Did you 
correlate fibrin deposition or the surface area of endothelial- 
like cells with subintimal thickness? This relates to the 
question that Dr. Kohler raised and was glossed over 
earlier: the role of nitric oxide as a mediator in determining 
subintimal thickness. 
We have studied aseries of rats in which we have given 
L-NAME, a nitric oxide inhibitor, after creating increased 
shear stress in a denuded carotid artery. It might be 
interesting to look at giving L-NAME to your animals and 
then mapping endothelial-like c ll deposition and correlat- 
ing that with subendothelial thickness to determine if nitric 
oxide may be the mediator that causes the fluctuations in 
the subendothelial thickness. 
Dr. Wu. The flow surface ndothelialization was evalu- 
ated on the entire surface of the specimen with silver nitrate 
staining, so we can only characterize it as endothelial-like 
cell coverage. The thickness of the neointima was measured 
microscopically from tissue samples covered with endothe- 
lial cells. 
In this study we did not look at the role of nitric oxide 
in the inhibition of intimal hyperplasia. 
